1Globe Capital LLC - 13 Aug 2025 SCHEDULE 13G Report for Crescent Biopharma, Inc. Ordinary Shares, par value $0.001 per share

Filing Manager: 1Globe Capital LLC
Reporting Manager: 1Globe Capital LLC
Security: Crescent Biopharma, Inc. Ordinary Shares, par value $0.001 per share
Shares outstanding: 13,902,512 shares
Disclosed Ownership: 896,712 shares
Ownership: 6.4%
Form type: SCHEDULE 13G
Filing time: 20 Aug 2025, 17:20:22 UTC
Date of event: 13 Aug 2025
Next filing: 14 Oct 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
1Globe Capital LLC	6.4%	896,712	0	896,712	/s/ Jiaqiang Li	Chairman
Jiaqiang Li	6.4%	896,712	0	896,712	/s/ Jiaqiang Li	Reporting person